{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T19:50:19Z","timestamp":1792439419756,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2006,9,5]],"date-time":"2006-09-05T00:00:00Z","timestamp":1157414400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1038\/sj.ijo.0803446","type":"journal-article","created":{"date-parts":[[2006,9,5]],"date-time":"2006-09-05T16:28:29Z","timestamp":1157473709000},"page":"494-499","source":"Crossref","is-referenced-by-count":122,"title":["Cetilistat (ATL-962), a novel lipase inhibitor: a 12-week randomized, placebo-controlled study of weight reduction in obese patients"],"prefix":"10.1038","volume":"31","author":[{"given":"P","family":"Kopelman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Bryson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Hickling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Rissanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Rossner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Toubro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Valensi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,9,5]]},"reference":[{"key":"BF0803446_CR1","unstructured":"World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000; 894: i\u2013xii, 1\u2013253."},{"key":"BF0803446_CR2","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1161\/01.CIR.67.5.968","volume":"67","author":"HB Hubert","year":"1983","unstructured":"Hubert HB, Feinleib M, McNamara PM, Castelli WP . Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67: 968\u2013977.","journal-title":"Circulation"},{"issue":"Suppl B","key":"BF0803446_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/eurheartj\/8.suppl_B.57","volume":"8","author":"S MacMahon","year":"1987","unstructured":"MacMahon S, Cutler J, Brittain E, Higgins M . Obesity and hypertension: epidemiological and clinical issues. Eur Heart J 1987; 8 (Suppl B): 57\u201370.","journal-title":"Eur Heart J"},{"issue":"Suppl 2","key":"BF0803446_CR4","doi-asserted-by":"publisher","first-page":"211s","DOI":"10.1002\/j.1550-8528.1995.tb00466.x","volume":"3","author":"G Blackburn","year":"1995","unstructured":"Blackburn G . Effect of degree of weight loss on health benefits. Obes Res 1995; 3 (Suppl 2): 211s\u2013216s.","journal-title":"Obes Res"},{"issue":"Suppl 4","key":"BF0803446_CR5","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1038\/sj.ijo.0802215","volume":"26","author":"J Vidal","year":"2002","unstructured":"Vidal J . Updated review on the benefits of weight loss. Int J Obes Relat Metab Disord 2002; 26 (Suppl 4): S25\u2013S28.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BF0803446_CR6","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/oby.2000.32","volume":"8","author":"IL Mertens","year":"2000","unstructured":"Mertens IL, Van Gaal LF . Overweight, obesity, and blood pressure: the effects of modest weight reduction. Obes Res 2000; 8: 270\u2013278.","journal-title":"Obes Res"},{"key":"BF0803446_CR7","first-page":"397","volume":"16","author":"DJ Goldstein","year":"1992","unstructured":"Goldstein DJ . Beneficial health effects of modest weight loss. Int J Obes Relat Metab Disord 1992; 16: 397\u2013415.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BF0803446_CR8","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/sj.ijo.0801128","volume":"24","author":"N Finer","year":"2000","unstructured":"Finer N, James WP, Kopelman PG, Lean ME, Williams G . One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor. Int J Obes Relat Metab Disord 2000; 24: 306\u2013313.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BF0803446_CR9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0140-6736(97)11509-4","volume":"352","author":"L Sj\u00f6str\u00f6m","year":"1998","unstructured":"Sj\u00f6str\u00f6m L, Rissanen A, Andersen T, Boldrin M, Golay A, Koppeschaar HP et al. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet 1998; 352: 167\u2013172.","journal-title":"Lancet"},{"key":"BF0803446_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1001\/jama.281.3.235","volume":"281","author":"MH Davidson","year":"1999","unstructured":"Davidson MH, Hauptman J, DiGirolamo M, Foreyt JP, Halsted CH, Heber D et al. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial. JAMA 1999; 281: 235\u2013242.","journal-title":"JAMA"},{"issue":"Suppl 1","key":"BF0803446_CR11","first-page":"S1","volume":"26","author":"C Dunk","year":"2002","unstructured":"Dunk C, Enunwa M, De la Motte S, Palmer RMJ . Increased faecal fat excretion in normal volunteers treated with lipase inhibitor ATL-962. Int J Obes Relat Metab Disord 2002; 26 (Suppl 1): S1\u2013S245.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BF0803446_CR12","first-page":"221","volume":"19","author":"ML Drent","year":"1995","unstructured":"Drent ML, Larsson I, William-Olsson T, Quaade F, Czubayko F, von Bergmann K et al. Orlistat (Ro 18-0647), a lipase inhibitor, in the treatment of human obesity: a multiple dose study. Int J Obes Relat Metab Disord 1995; 19: 221\u2013226.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BF0803446_CR13","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s002280050433","volume":"54","author":"LF Van Gaal","year":"1998","unstructured":"Van Gaal LF, Broom JI, Enzi G, Toplak H . Efficacy and tolerability of orlistat in the treatment of obesity: a 6-month dose-ranging study. Orlistat Dose-Ranging Study Group. Eur J Clin Pharmacol 1998; 54: 125\u2013132.","journal-title":"Eur J Clin Pharmacol"},{"key":"BF0803446_CR14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/sj.ijo.0800540","volume":"22","author":"C Hanotin","year":"1998","unstructured":"Hanotin C, Thomas F, Jones SP, Leutenegger E, Drouin P . Efficacy and tolerability of sibutramine in obese patients: a dose ranging study. Int J Obes Relat Metabol Disord 1998; 22: 32\u201338.","journal-title":"Int J Obes Relat Metabol Disord"},{"issue":"Suppl 1","key":"BF0803446_CR15","first-page":"530","volume":"21","author":"ME Lean","year":"1997","unstructured":"Lean ME . Sibutramine \u2013 a review of clinical efficacy. Int J Obes Relat Metab Disord 1997; 21 (Suppl 1): 530\u2013536 (discussion 37\u201339).","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"Suppl 1","key":"BF0803446_CR16","first-page":"S27","volume":"28","author":"M Jensen","year":"2004","unstructured":"Jensen M, Abu-Lebdeh H, Geohas J, Brazg R, Block M, Noveck R et al. The selective CB1 receptor antagonist rimonabant reduces bodyweight and waste circumference in obese subjects. Int J Obes Relat Metab Disord 2004; 28 (Suppl 1): S27.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BF0803446_CR17","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S0140-6736(05)66374-X","volume":"365","author":"LF Van Gaal","year":"2005","unstructured":"Van Gaal LF, Rissanen AM, Scheen AJ, Ziegler O, Rossner S . Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. Lancet 2005; 365: 1389\u20131397.","journal-title":"Lancet"},{"key":"BF0803446_CR18","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1001\/archinte.1987.00370100063012","volume":"147","author":"RR Wing","year":"1987","unstructured":"Wing RR, Koeske R, Epstein LH, Nowalk MP, Gooding W, Becker D . Long-term effects of modest weight loss in type II diabetic patients. Arch Intern Med 1987; 147: 1749\u20131753.","journal-title":"Arch Intern Med"},{"key":"BF0803446_CR19","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3122\/jabfm.17.5.359","volume":"17","author":"AJ Orzano","year":"2004","unstructured":"Orzano AJ, Scott JG . Diagnosis and treatment of obesity in adults: an applied evidence-based review. J Am Board Fam Pract 2004; 17: 359\u2013369.","journal-title":"J Am Board Fam Pract"},{"key":"BF0803446_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1161\/01.ATV.4.2.115","volume":"4","author":"J Zimmerman","year":"1984","unstructured":"Zimmerman J, Kaufmann NA, Fainaru M, Eisenberg S, Oschry Y, Friedlander Y et al. Effect of weight loss in moderate obesity on plasma lipoprotein and apolipoprotein levels and on high density lipoprotein composition. Arteriosclerosis 1984; 4: 115\u2013123.","journal-title":"Arteriosclerosis"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/0803446.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/0803446","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/0803446.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T07:39:22Z","timestamp":1684222762000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/0803446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9,5]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["BF0803446"],"URL":"https:\/\/doi.org\/10.1038\/sj.ijo.0803446","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9,5]]}}}